This peptide-pathway test examines 14 metabolic and digestive signaling pathways across 49 peptides and 150+ genetic insights, including variants like MC4R rs17782313 that influence how your body responds to GLP-1 activation
Presented for research literature review only Pevec D et al
Gastrointestinal Side Effects There can be gastrointestinal side effects, including nausea and vomiting for some people, which are usually manageable
At the time of writing, retatrutide is not FDA approved for weight loss or diabetes treatment in the United States
DA: Visualization, Resources, Data curation, Validation, Writing review & editing, Writing original draft, Investigation
By combining both actions, tirzepatide in Mounjaro gives a stronger effect on weight loss and blood sugar control than treatments that use GLP-1 alone